Navigation Links
Medarex Announces 2008 First Quarter Financial Results
Date:5/12/2008

1,300 1,530

Other assets 2,206 3,415

$690,775 $759,860

Current liabilities $64,319 $81,645

Other liabilities 86,170 89,454

Convertible notes 143,986 143,505

Shareholders' equity 396,300 445,256

$690,775 $759,860

(1) Derived from the December 31, 2007 audited financial statements. For

further information, refer to the consolidated financial statements

and footnotes thereto included in Medarex's Annual Report on Form 10-K

for the year ended December 31, 2007.

This press release dated May 12, 2008, contains non-GAAP financial measures. The following table reconciles the non-GAAP financial measures contained in the press release to the most directly comparable financial measures prepared in accordance with GAAP. These non-GAAP financial measures include non-GAAP net loss and non-GAAP net loss per share. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.

The following reconciliation of GAAP net income to non-GAAP net loss and GAAP net income per share to non-GAAP net loss per share is provided as a complement to results presented in accordance with GAAP because Medarex's management believes these non-GAAP financial measures provide better insight into Medarex's performance by focusing on results generated by its ongoing operations and are important in comparing current results with prior period results. Non-GAAP net loss and non-GAAP net loss per share are intended to illustrate Medarex's results of operations for the periods present
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
2. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
3. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
5. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
6. Medarex to Present at the JPMorgan Small/Mid Cap Conference
7. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
8. Medifast Announces First Quarter 2008 Financial Results
9. Esperanza Announces Support of H.R. 1108, Encourages Congress to Pass FDA Regulation of Tobacco
10. Pregis Announces First Quarter 2008 Financial Results
11. Almost Family, Inc. Announces Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...s gain benefit from calcitriol, an oral form , ... activated vitamin D may cut the risk of death for...ease by about one quarter, a new study suggests. ...tients, those being treated with calcitriol, an or...risk of death lowered by 26 percent when compared ...
(Date:5/16/2008)... Frail Seniors and People With,Disabilities, OAKL...usands of,homecare workers across the state are ou...ts to hours of service, wages and benefits,which ...orkers and the,people they serve deeper into pover...seniors and people with disabilities from Schwarze...
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
Breaking Medicine News(10 mins):Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4
...the cause of 90 percent of the world’s lung cancer...mber of cigarettes they smoke per day are exposed ...r cancer-causing agent. However, the reduction in ...n exposure is often temporary and not proportional...
...ey have found a gene that predisposes people to be... // involving 262 families with alcoholic members ...romosome 15 that had previously been linked to alc...s -- GABRG3 -- did appear to influence alcoholism ...
...he abilities required for success in school are si...ce.// The idea that one’s cognitive abilities pre...l world has been controversial. Many people believ...t than what is need for academic success. Scientis...
...acement surgery has been the only treatment for a ...r some younger patients may replace the traditiona...l’s golf team. But a broken hip in grade school le...Decreased blood flow caused his hip joint to die. ...
Other Medicine News:Health News:Reducing Number Of Cigarettes Not Enough 2
(Date:5/15/2008)...y Remains for an Antiplatelet Therapy that, Combin...mbination of Plavix/Iscover and Aspirin, Accor...THAM, Mass., May 15 /- Decision Resou...sory firms for pharmaceutical and,healthcare issue...ffers,improvement in patient compared to Sanofi-Av...
(Date:5/15/2008)...d soon after CEA Trial data reports in third quart...ISCO, May 15 /- VIA Pharmac...ompany focused on the development of,compounds for...d today that,it has completed patient enrollment i... study is one of three Phase 2 trials investigatin...
(Date:5/15/2008)...the 21st Annual Meeting of The American Society of...Meeting -, IRVINE, Calif., May 15 /PRNewswire-Fir... IDMI ) today announced the presentation of updat...ting mifamurtide (L-MTP-PE) in,patients with lung ...sarcoma, a rare and often fatal bone tumor that ty...
(Date:5/14/2008)..., May 14 /- Progen,Pharmace...unced that the,Company has resumed patient enrolme...ently acquired polyamine analogue, PG-11047 (forme... Progen has commenced development of PG-11047 - t...ne program - following its acquisition of,Cellgate...
Breaking Medicine Technology:Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 1Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 3Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 4Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 5Author Kris Carr to Sign Crazy Sexy Cancer Tips at Two Borders 28R 29 Stores in California 664 1Author Kris Carr to Sign Crazy Sexy Cancer Tips at Two Borders 28R 29 Stores in California 664 2Youth Drug Use at a Five Year Low New Survey Shows 662 1Youth Drug Use at a Five Year Low New Survey Shows 662 2Youth Drug Use at a Five Year Low New Survey Shows 662 3Dr Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance 660 1Dr Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance 660 2
...ing with wireless connectivity, ,The wireless fun...toring system that makes it possible to connect S/...ation via Wireless LAN technology., ,Wireless ope...entralized surveillance within the care unit. It a...
...onitoring, ,The Deltatrac II is a complete metabo.... It's ideal for use with a ventilator or a canopy...hing and mechanically ventilated patients of all a...ally ill patients vary extremely; both overfeeding...
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces.
For accurately monitoring core temperature and heart and breath sounds.
Medicine Products: